DrugPatentWatch Database Preview
Novast Labs Company Profile
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has forty-three approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 29 |
| NDAs: | 43 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs Ltd | TRI-LINYAH | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090524-001 | May 30, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 205087-001 | Sep 23, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 091451-001 | Sep 21, 2012 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Novast Labs | NADOLOL | nadolol | TABLET;ORAL | 210786-001 | Jun 1, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
